A systematic review of strategies adopted to scale up COVID-19 testing in low-, middle- and high-income countries
- PMID: 36396316
- PMCID: PMC9676418
- DOI: 10.1136/bmjopen-2022-060838
A systematic review of strategies adopted to scale up COVID-19 testing in low-, middle- and high-income countries
Abstract
Objective: We undertook a systematic review of strategies adopted to scale up COVID-19 testing in countries across income levels to identify successful approaches and facilitate learning.
Methods: Scholarly articles in English from PubMed, Google scholar and Google search engine describing strategies used to increase COVID-19 testing in countries were reviewed. Deductive analysis to allocate relevant text from the reviewed publications/reports to the a priori themes was done.
Main results: The review covered 32 countries, including 11 high-income, 2 upper-middle-income, 13 lower-middle-income and 6 low-income countries. Most low- and middle-income countries (LMICs) increased the number of laboratories available for testing and deployed sample collection and shipment to the available laboratories. The high-income countries (HICs) that is, South Korea, Germany, Singapore and USA developed molecular diagnostics with accompanying regulatory and legislative framework adjustments to ensure the rapid development and use of the tests. HICs like South Korea leveraged existing manufacturing systems to develop tests, while the LMICs leveraged existing national disease control programmes (HIV, tuberculosis, malaria) to increase testing. Continent-wide, African Centres for Disease Control and Prevention-led collaborations increased testing across most African countries through building capacity by providing testing kits and training.
Conclusion: Strategies taken appear to reflect the existing systems or economies of scale that a particular country could leverage. LMICs, for example, drew on the infectious disease control programmes already in place to harness expertise and laboratory capacity for COVID-19 testing. There however might have been strategies adopted by other countries but were never published and thus did not appear anywhere in the searched databases.
Keywords: COVID-19; health policy; public health.
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures
Similar articles
-
Telehealth services for global emergencies: implications for COVID-19: a scoping review based on current evidence.BMC Health Serv Res. 2023 Jun 1;23(1):567. doi: 10.1186/s12913-023-09584-4. BMC Health Serv Res. 2023. PMID: 37264401 Free PMC article.
-
Cost-effectiveness of COVID rapid diagnostic tests for patients with severe/critical illness in low- and middle-income countries: A modeling study.PLoS Med. 2024 Jul 18;21(7):e1004429. doi: 10.1371/journal.pmed.1004429. eCollection 2024 Jul. PLoS Med. 2024. PMID: 39024370 Free PMC article.
-
The challenges of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing in low-middle income countries and possible cost-effective measures in resource-limited settings.Global Health. 2022 Jan 22;18(1):5. doi: 10.1186/s12992-022-00796-7. Global Health. 2022. PMID: 35065670 Free PMC article. Review.
-
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881. Med J Aust. 2020. PMID: 33314144
-
Public sector reforms and their impact on the level of corruption: A systematic review.Campbell Syst Rev. 2021 May 24;17(2):e1173. doi: 10.1002/cl2.1173. eCollection 2021 Jun. Campbell Syst Rev. 2021. PMID: 37131927 Free PMC article. Review.
Cited by
-
A Cross-Border Biorisk Toolkit for Healthcare Professionals.Int J Environ Res Public Health. 2024 Sep 23;21(9):1261. doi: 10.3390/ijerph21091261. Int J Environ Res Public Health. 2024. PMID: 39338144 Free PMC article.
-
Assessing time requirements of two models of SARS-CoV-2 screening and testing in routine healthcare services in Kenya and Cameroon: a descriptive study.BMJ Public Health. 2025 Mar 22;2(Suppl 1):e001154. doi: 10.1136/bmjph-2024-001154. eCollection 2024 Jul. BMJ Public Health. 2025. PMID: 40599610 Free PMC article.
-
Ensuring diagnostic testing accuracy for patient care and public health- COVID-19 testing scale-up from an EQA provider's perspective.PLOS Glob Public Health. 2023 Dec 6;3(12):e0001615. doi: 10.1371/journal.pgph.0001615. eCollection 2023. PLOS Glob Public Health. 2023. PMID: 38055697 Free PMC article.
-
Qualitative assessment of the scale-up of COVID-19 testing network in Armenia: turning adversities into opportunities.BMC Public Health. 2025 Feb 14;25(1):611. doi: 10.1186/s12889-025-21776-7. BMC Public Health. 2025. PMID: 39953481 Free PMC article.
-
Factors associated with COVID-19 vaccination rates in countries with different income levels: a panel analysis.BMC Public Health. 2024 Dec 19;24(1):3538. doi: 10.1186/s12889-024-20973-0. BMC Public Health. 2024. PMID: 39702068 Free PMC article.
References
-
- COVID-19 Map - Johns Hopkins Coronavirus Resource Center . Available: https://coronavirus.jhu.edu/map.html [Accessed 17 Dec 2021].
-
- WHO Director-General’s opening remarks at the media briefing on COVID-19, 2020. Available: https://www.who.int/director-general/speeches/detail/who-director-genera... [Accessed 28 Sep 2021].
-
- Rough E. Coronavirus: testing for Covid-19, 2020. Available: www.parliament.uk/commons-library|intranet.parliament.uk/commons-library... [Accessed 27 Sep 2021].
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical